Pulmonary responses to subacute ozone exposure in obese vs. lean mice

Journal of Applied Physiology

Volumn 107, Issue 5, 2009, Pages 1445-1452

  Shore, Stephanie A ^a   Lang, Jason E ^a   Kasahara, David I ^a   Lu, Frank L ^a,b   Verbout, Norah G ^a   Si, Huiqing ^a   Williams, Erin S ^a   Terry, Raya D ^a   Lee, Anna ^a   Johnston, Richard A ^a  

^a HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

^b NATIONAL TAIWAN UNIVERSITY HOSPITAL   (Taiwan)

Author keywords

Dynamic compliance; Macrophage; Neutrophil; Pulmonary resistance; sTNFR1

Indexed keywords

INTERLEUKIN 6; LEPTIN; OZONE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; FEMALE; LUNG COMPLIANCE; LUNG FUNCTION; LUNG INJURY; MALE; MOUSE; NONHUMAN; OBESITY; PNEUMONIA; PRIORITY JOURNAL; PROTEIN FUNCTION; SIGNAL TRANSDUCTION;

ANIMALS; ENVIRONMENTAL EXPOSURE; INTERLEUKIN-6; LUNG; MICE; OBESITY; OZONE; RESPIRATORY MECHANICS; THINNESS;

EID: 72749111392     PISSN: 87507587     EISSN: 15221601     Source Type: Journal    
DOI: 10.1152/japplphysiol.00456.2009     Document Type: Article

References (48)

1. Aneja VP, Yoder GT, Arya SP. Ozone in the urban southeastern United States. Environ Pollut 75: 39-44, 1992.
2. Bastard JP, Jardel C, Bruckert E, Blondy P, Capeau J, Laville M, Vidal H, Hainque B. Elevated levels of interleukin 6 are reduced in serum and subcutaneous adipose tissue of obese women after weight loss. J Clin Endocrinol Metab 85: 3338-3342, 2000. (Pubitemid 30944547)
3. Bellmeyer A, Martino JM, Chandel NS, Scott Budinger GR, Dean DA, Mutlu GM. Leptin resistance protects mice from hyperoxia-induced acute lung injury. Am J Respir Crit Care Med 175: 587-594, 2007. (Pubitemid 46438943)
4. Bennett WD, Hazucha MJ, Folinsbee LJ, Bromberg PA, Kissling GE, London SJ. Acute pulmonary function response to ozone in young adults as a function of body mass index. Inhal Toxicol 19: 1147-1154, 2007.
5. Bhalla DK. Ozone-induced lung inflammation and mucosal barrier disruption: toxicology, mechanisms, and implications. J Toxicol Environ Health B Crit Rev 2: 31-86, 1999.
6. Biasucci LM, Liuzzo G, Fantuzzi G, Caligiuri G, Rebuzzi AG, Ginnetti F, Dinarello CA, Maseri A. Increasing levels of interleukin (IL)-1Ra and IL-6 during the first 2 days of hospitalization in unstable angina are associated with increased risk of in-hospital coronary events. Circulation 99: 2079-2084, 1999. (Pubitemid 29196789)
7. Chen H, Charlat O, Tartaglia LA, Woolf EA, Weng X, Ellis SJ, Lakey ND, Culpepper J, Moore KJ, Breitbart RE, Duyk GM, Tepper RI, Morgenstern JP. Evidence that the diabetes gene encodes the leptin receptor: identification of a mutation in the leptin receptor gene in db/db mice. Cell 84: 491-495, 1996. (Pubitemid 26060722)
8. Cho HY, Morgan DL, Bauer AK, Kleeberger SR. Signal transduction pathways of tumor necrosis factor-mediated lung injury induced by ozone in mice. Am J Respir Crit Care Med 175: 829-839, 2007.
9. Cho HY, Zhang LY, Kleeberger SR. Ozone-induced lung inflammation and hyperreactivity are mediated via tumor necrosis factor-alpha receptors. Am J Physiol Lung Cell Mol Physiol 280: L537-L546, 2001. (Pubitemid 32473205)
10. Devlin RB, McDonnell WF, Mann R, Becker S, House DE, Schreinemachers D, Koren HS. Exposure of humans to ambient levels of ozone for 6.6 hours causes cellular and biochemical changes in the lung. Am J Respir Cell Mol Biol 4: 72-81, 1991.
11. Gao H, Ward PA. STAT3 and suppressor of cytokine signaling 3: potential targets in lung inflammatory responses. Expert Opin Ther Targets 11: 869-880, 2007. (Pubitemid 47061314)
12. Gent JF, Triche EW, Holford TR, Belanger K, Bracken MB, Beckett WS, Leaderer BP. Association of low-level ozone and fine particles with respiratory symptoms in children with asthma. JAMA 290: 1859-1867, 2003.
13. Heinrich PC, Behrmann I, Haan S, Hermanns HM, Muller-Newen G, Schaper F. Principles of interleukin (IL)-6-type cytokine signalling and its regulation. Biochem J 374: 1-20, 2003. (Pubitemid 37046923)
14. Hino T, Nakamura H, Abe S, Saito H, Inage M, Terashita K, Kato S, Tomoike H. Hydrogen peroxide enhances shedding of type I soluble tumor necrosis factor receptor from pulmonary epithelial cells. Am J Respir Cell Mol Biol 20: 122-128, 1999. (Pubitemid 129504850)
15. Hollingsworth JW 2nd, Cook DN, Brass DM, Walker JK, Morgan DL, Foster WM, Schwartz DA. The role of Toll-like receptor 4 in environmental airway injury in mice. Am J Respir Crit Care Med 170: 126-132, 2004.
16. Huber SA, Sakkinen P, Conze D, Hardin N, Tracy R. Interleukin-6 exacerbates early atherosclerosis in mice. Arterioscler Thromb Vasc Biol 19: 2364-2367, 1999. (Pubitemid 29477837)
17. Johnston RA, Mizgerd JP, Flynt L, Quinton LJ, Williams ES, Shore SA. Type I interleukin-1 receptor is required for pulmonary responses to subacute ozone exposure in mice. Am J Respir Cell Mol Biol 37: 477-484, 2007. (Pubitemid 47502723)
18. Johnston RA, Schwartzman IN, Flynt L, Shore SA. Role of interleukin-6 in murine airway responses to ozone. Am J Physiol Lung Cell Mol Physiol 288: L390-L397, 2005. (Pubitemid 40105379)
19. Johnston RA, Theman TA, Lu FL, Terry RD, Williams ES, Shore SA. Diet-induced obesity causes innate airway hyperresponsiveness to methacholine and enhances ozone-induced pulmonary inflammation. J Appl Physiol 104: 1727-1735, 2008.
20. Johnston RA, Theman TA, Shore SA. Augmented responses to ozone in obese carboxypeptidase e-deficient mice. Am J Physiol Regul Integr Comp Physiol 290: R126-R133, 2006.
21. Johnston RA, Theman TA, Terry RD, Williams ES, Shore SA. Pulmonary responses to acute ozone exposure in fasted mice: effect of leptin administration. J Appl Physiol 102: 149-156, 2007.
22. Kile BT, Alexander WS. The suppressors of cytokine signalling (SOCS). Cell Mol Life Sci 58: 1627-1635, 2001.
23. Kleeberger SR, Levitt RC, Zhang LY. Susceptibility to ozone-induced inflammation. I. Genetic control of the response to subacute exposure. Am J Physiol Lung Cell Mol Physiol 264: L15-L20, 1993. (Pubitemid 23056730)
24. Kleeberger SR, Levitt RC, Zhang LY. Susceptibility to ozone-induced inflammation. II. Separate loci control responses to acute and subacute exposures. Am J Physiol Lung Cell Mol Physiol 264: L21-L26, 1993.
25. Kleeberger SR, Levitt RC, Zhang LY, Longphre M, Harkema J, Jedlicka A, Eleff SM, DiSilvestre D, Holroyd KJ. Linkage analysis of susceptibility to ozone-induced lung inflammation in inbred mice. Nat Genet 17: 475-478, 1997. (Pubitemid 27518401)
26. Lang JE, Williams ES, Mizgerd JP, Shore SA. Effect of obesity on pulmonary inflammation induced by acute ozone exposure: role of interleukin-6. Am J Physiol Lung Cell Mol Physiol 294: L1013-L1020, 2008.
27. Lee DL, Sturgis LC, Labazi H, Osborne JB Jr, Fleming C, Pollock JS, Manhiani M, Imig JD, Brands MW. Angiotensin II hypertension is attenuated in interleukin-6 knockout mice. Am J Physiol Heart Circ Physiol 290: H935-H940, 2006.
28. Leibel RL, Chung WK, Chua SC Jr. The molecular genetics of rodent single gene obesities. J Biol Chem 272: 31937-31940, 1997. (Pubitemid 28011856)
29. Lu FL, Johnston RA, Flynt L, Theman TA, Terry RD, Schwartzman IN, Lee A, Shore SA. Increased pulmonary responses to acute ozone exposure in obese db/db mice. Am J Physiol Lung Cell Mol Physiol 290: L856-L865, 2006. (Pubitemid 43725047)
30. Michalec L, Choudhury BK, Postlethwait E, Wild JS, Alam R, Lett-Brown M, Sur S. CCL7 and CXCL10 orchestrate oxidative stress-induced neutrophilic lung inflammation. J Immunol 168: 846-852, 2002. (Pubitemid 34049587)
31. Pitombo C, Araujo EP, De Souza CT, Pareja JC, Geloneze B, Velloso LA. Amelioration of diet-induced diabetes mellitus by removal of visceral fat. J Endocrinol 191: 699-706, 2006. (Pubitemid 46210294)
32. Pradhan AD, Manson JE, Rifai N, Buring JE, Ridker PM. C-reactive protein, interleukin 6, and risk of developing type 2 diabetes mellitus. JAMA 286: 327-334, 2001. (Pubitemid 32656163)
33. Ridker PM, Rifai N, Stampfer MJ, Hennekens CH. Plasma concentration of interleukin-6 and the risk of future myocardial infarction among apparently healthy men. Circulation 101: 1767-1772, 2000. (Pubitemid 30213096)
34. Rivera-Sanchez YM, Johnston RA, Schwartzman IN, Valone J, Silverman ES, Fredberg JJ, Shore SA. Differential effects of ozone on airway and tissue mechanics in obese mice. J Appl Physiol 96: 2200-2206, 2004. (Pubitemid 38661502)
35. Serino M, Menghini R, Fiorentino L, Amoruso R, Mauriello A, Lauro D, Sbraccia P, Hribal ML, Lauro R, Federici M. Mice heterozygous for tumor necrosis factor-alpha converting enzyme are protected from obesity-induced insulin resistance and diabetes. Diabetes 56: 2541-2546, 2007.
36. Shore SA, Johnston RA. Obesity and asthma. Pharmacol Ther 110: 83-102, 2006.
37. Shore SA, Rivera-Sanchez YM, Schwartzman IN, Johnston RA. Responses to ozone are increased in obese mice. J Appl Physiol 95: 938-945, 2003.
38. Shore SA, Schwartzman IN, Le Blanc B, Murthy GG, Doerschuk CM. Tumor necrosis factor receptor 2 contributes to ozone-induced airway hyperresponsiveness in mice. Am J Respir Crit Care Med 164: 602-607, 2001. (Pubitemid 32807685)
39. Skurk T, Van Harmelen V, Lee YM, Wirth A, Hauner H. Relationship between IL-6, leptin and adiponectin and variables of fibrinolysis in overweight and obese hypertensive patients. Horm Metab Res 34: 659-663, 2002. (Pubitemid 36398703)
40. Tankersley CG, Kleeberger SR. Ozone-induced inflammation and altered ventilation in genetically susceptible mice: a comparison of acute and subacute exposures. Toxicol Lett 72: 279-289, 1994.
41. Teramoto S, Yamamoto H, Ouchi Y. Increased C-reactive protein and increased plasma interleukin-6 may synergistically affect the progression of coronary atherosclerosis in obstructive sleep apnea syndrome. Circulation 107: E40-40, 2003.
42. Tolbert PE, Mulholland JA, MacIntosh DL, Xu F, Daniels D, Devine OJ, Carlin BP, Klein M, Dorley J, Butler AJ, Nordenberg DF, Frumkin H, Ryan PB, White MC. Air quality and pediatric emergency room visits for asthma in Atlanta, Georgia, USA. Am J Epidemiol 151: 798-810, 2000.
43. U.S. Environmental Protection Agency. Air Quality Criteria for Ozone and Other Photochemical Oxidants. Research Triangle Park, NC: U.S. EPA, 1986, vol.IV.
44. Vozarova B, Weyer C, Hanson K, Tataranni PA, Bogardus C, Pratley RE. Circulating interleukin-6 in relation to adiposity, insulin action, and insulin secretion. Obes Res 9: 414-417, 2001. (Pubitemid 33603868)
45. Weisberg SP, McCann D, Desai M, Rosenbaum M, Leibel RL, Ferrante AW Jr. Obesity is associated with macrophage accumulation in adipose tissue. J Clin Invest 112: 1796 - 1808, 2003.
46. Weister MJ, Williams TB, King E, Menache MG, Muller FJ. Ozone uptake in awake Sprague-Dawley rats. Toxicol Appl Pharmacol 89: 429-437, 1987.
47. Williams AS, Issa R, Leung SY, Nath P, Ferguson GD, Bennett BL, Adcock IM, Chung KF. Attenuation of ozone-induced airway inflammation and hyper-responsiveness by c-Jun NH2 terminal kinase inhibitor SP600125. J Pharmacol Exp Ther 322: 351-359, 2007. (Pubitemid 46956362)
48. Yu M, Zheng X, Witschi H, Pinkerton KE. The role of interleukin-6 in pulmonary inflammation and injury induced by exposure to environmental air pollutants. Toxicol Sci 68: 488-497, 2002. (Pubitemid 34919192)